The FDA will grant the University of Rochester Medical Center a $4.5 million grant over five years to study different approaches to improve methods used to evaluate and approve treatments for acute and chronic pain, according to a University news release.
Clinical trials of pain medication often produce less-than-ideal results because the control group, or patients receiving a placebo, often improve more than expected. A team of researchers will explore how the design of chronic and acute pain trials can be improved.
Related Articles on Pain Management:
Physicians Struggle to Treat Pain During Opioid Abuse Epidemic
Study: Naltrexone Use Prevents Relapse of Opioid Dependency
Nano-formulated NSAIDs Provide Relief at Lower Doses
Clinical trials of pain medication often produce less-than-ideal results because the control group, or patients receiving a placebo, often improve more than expected. A team of researchers will explore how the design of chronic and acute pain trials can be improved.
Related Articles on Pain Management:
Physicians Struggle to Treat Pain During Opioid Abuse Epidemic
Study: Naltrexone Use Prevents Relapse of Opioid Dependency
Nano-formulated NSAIDs Provide Relief at Lower Doses